Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03354520

Optimizing Treatment Effects on OSA-related Clinical and Patient-centered Outcomes Among Blacks

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is to maximize efficacy of message delivery to achieve desired Obstructive sleep apnea (OSA) adherence goal. Newly diagnosed black patients (n=390, all genders) from participating sleep clinics will be randomly exposed to either the individually tailored or standard OSA messages. Investigators will look at an effective and scalable intervention to improve OSA-related outcomes: a) clinical CVD and brain health measures and b) patient-centered outcomes. Patient-centered and adherence data will be captured via REDCap, enabling real-time application of data-driven decision rules while implementing the intervention.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTailored Videosweb-based OSA messages (videos featuring role models and coaching advice using motivational enhancement) addressing OSA barriers within a health literacy framework--to decrease cognitive load and render messages understandable and actionable. OSA messages were tailored based on focus group data in the previous study (group tailoring).
BEHAVIORALOSA TreatmentWeb-based platform delivering messages promoting OSA self-efficacy. . All patients will view the introductory video, followed by the video cluster: Sleep, Health, and Well-Being; Sleep-Heart Health; Lifestyle Changes; and Sleep Hygiene.
BEHAVIORALStandard VideosPatients in the control arm will also receive an iPad, providing access to standard online OSA health information (e.g., National Sleep Foundation) in an equivalent dose as in the intervention arm using pre-selected automatic alerts to access the website

Timeline

Start date
2021-06-18
Primary completion
2021-06-18
Completion
2021-06-18
First posted
2017-11-28
Last updated
2022-02-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03354520. Inclusion in this directory is not an endorsement.